Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

Abstract Background Esophageal adenocarcinoma is a lethal disease. For locally advanced patients, neoadjuvant chemoradiotherapy followed by surgery is the standard of care. Risk stratification relies heavily on clinicopathologic features, particularly pathologic response, which is inadequate, theref...

Full description

Bibliographic Details
Main Authors: Hirsch Matani, Divya Sahu, Michael Paskewicz, Anastasia Gorbunova, Ashten N. Omstead, Rodney Wegner, Gene G. Finley, Blair A. Jobe, Ronan J. Kelly, Ali H. Zaidi, Ajay Goel
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Biomarker Research
Subjects:
Esophageal adenocarcinoma
Risk stratification
CROSS regimen
EPHA5
BCL6
ERBB2
Online Access:https://doi.org/10.1186/s40364-022-00429-6

Internet

https://doi.org/10.1186/s40364-022-00429-6

Similar Items